Increased clusterin expression in old but not young adult S100B transgenic mice: Evidence of neuropathological aging in a model of Down Syndrome

Brain Research

Volumn 1010, Issue 1-2, 2004, Pages 17-21

  Shapiro, Lee A ^a   Marks, Alexander ^b   Whitaker Azmitia, Patricia M ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aging processes; Clusterin expression; Development and regeneration; Down Syndrome; S100B transgenic mouse

Indexed keywords

CLUSTERIN; PROTEIN S100B;

ADOLESCENT; AGE DISTRIBUTION; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AGING; ANIMALS; BRAIN; CHROMOSOMES, HUMAN, PAIR 21; CLUSTERIN; DISEASE MODELS, ANIMAL; DOWN SYNDROME; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; NERVE GROWTH FACTORS; NEURONS; S100 PROTEINS; UP-REGULATION;

EID: 2342620177     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.12.057     Document Type: Article

References (35)

1. Allore R., O'Hanlon D., Price R., Neilson K., Willard H.F., Cox D.R., Marks A., Dunn R.J. Gene encoding the beta subunit of S-100 protein is on chromosome 21: implications for Down's syndrome. Science. 239:1988;1311-1313
2. Azmitia E.C., Dolan K., Whitaker-Azmitia P.M. S100β but not NGF, EGF, insulin or calmodulin function as a CNS serotonergic growth factor. Brain Res. 516:1990;354-360
3. Calero M., Rostagno A., Matsubara E., Zlokovic B., Frangione B., Ghiso J. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc. Res. Tech. 50:2000;305-315
4. Choi-Miura N.H., Oda T. Relationship between, multi-functional protein clusterin and Alzheimer's disease. Neurobiol. Aging. 17:1996;717-722
5. Demattos R.B, O'Dell M.A, Parsadanian M., Taylor J.W, Harmony J.A.K., Bales K.R., Paul S.M., Aronow B.J, Holtzman D.M. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10843-10848
6. Donato R. Perspectives in S100 protein biology. Cell Calcium. 12:1991;713-726
7. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochem. Biophys. Acta. 1450:1999;191-231
8. Dragunow M., Preston K., Dodd J., Young D., Lawlor P., Christie D. Clusterin accumulates in dying neurons following status epilepticus. Mol. Brain Res. 32:1995;279-290
9. Fano G., Mariggio M.A., Angelella P., Nicoletti I., Antonica A., Fulle S., Calissano P. The S-100 protein causes an increase of intracellular calcium and death of PC12 Cells. Neuroscience. 53:1993;919-925
10. Friend W.C., Clapoff S., Landry C., Becker L.E., O'Hanlon D., Allore R.J., Brown I.R., Marks A., Roder J., Dunn R.J. Cell-specific expression of high levels of human S100 beta in transgenic mouse brain is dependent on gene dosage. J. Neurosci. 12:1992;4337-4346
11. Fulle S., Mariggio M.A., Belia S., Nicoletti I., Fano G. Nerve growth factor inhibits apoptosis induced by S100 binding in neuronal PC12 cells. Neuroscience. 76:1997;159-166
12. Giannakopoulos P., Kovari E., French L.E., Viard I., Hof P.R., Bouras C. Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta Neuropathol. (Berl.). 95:1998;387-394
13. Griffin W.S., Stanley L.C., Ling C., White L., Macleod V., Perrot L.J., White C.L., Araoz C. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's Disease. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7611-7615
14. Hardemark H.G., Ericsson N., Kotwica Z., Rundstrom G., Mendel-Hartvig I., Olsson Y., Pahlman S., Persson L. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J. Neurosurg. 71:1989;727-731
15. Jones S.E., Jomary C. Clusterin. Int. J. Biochem. Cell Biol. 34:2002;427-431
16. Kida E., Choi-Miura N.H., Wisniewski K.E. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain. Brain Res. 685:1995;211-216
17. Lidstrom A.M., Bogdanovic N., Hesse C., Volkman I., Davidsson P., Blennow K. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp. Neurol. 154:1998;511-521
18. Mariggio M.A., Fulle S., Calissano P., Nicoletti I., Fano G. The Brain Protein S100ab induces apoptosis in PC12 cells. Neuroscience. 60:1994;29-35
19. Marshak D.R., Pesce S.A., Stanley L.C., Griffen W.S.T. Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging. 13(1):1992;1-7
20. May P.C., Robison P., Fuson K., Smalstig B., Stephenson D., Clemens J.A. Sulfated glycoprotein-2 expression increases in rodent brain after transient global ischemia. Brain Res. Mol. Brain Res. 15:1992;33-39
21. McGeer P.L., Kawamata T., Walker D.G. Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579:1992;337-341
22. Messmer-Joudrier S., Sagot Y., Mattenberger L., James R.W., Kato A.C. Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells. Eur. J. Neurosci. 8:1996;2652-2661
23. Mrak R.E., Sheng J.G., Griffin W.S.T. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55(3):1996;273-279
24. Muller C.M., Akhavan A.C., Bette M. Possible role of S-100 in glia-neuronal signaling involved in activity dependent plasticity in the developing mammalian cortex. J. Chem. Neuroanat. 6:1993;215-220
25. Page K.J., Hollister R.D., Hyman B.T. Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study. Neuroscience. 85:1998;1161-1171
26. Pasinetti G.M., Johnson S.A., Oda T., Rozovsky I., Finch C.E. Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339:1994;387-400
27. Paxinos G., Franklin B.J. The Mouse Brain in Stereotaxic Coordinates. 2nd edition:2001;Academic Press, Hong Kong
28. Senut M.C., Jazat F., Choi N.H., Lamour Y. Protein SP40, 40-like immunoreactivity in the rat brain: progressive increase with age. Eur. J. Neurosci. 4(10):1992;917-921
29. Stoltzner S.E., Grenfell T.J., Mori C., Wisniewski K.E., Wisniewski T.M., Selkoe D.J., Lemere C.A. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Am. J. Pathol. 156:2000;489-499
30. Walton M., Young D., Sirimanne E., Dodd J., Christie D., Williams C., Gluckman P., Dargunow M. Induction of clusterin in the immature brain following a hypoxic-ischemic injury. Mol. Brain Res. 39:1996;137-152
31. Wehrli P., Charnay Y., Vallet P., Zhu G., Harmony J., Aronow B., Tschopp J., Bouras C., Viard-Leveugle I., French L.E., Giannakopoulos P. Inhibition of post-ischemic brain injury by clusterin overexpression. Nat. Med. 7:2001;977-979
32. Whitaker-Azmitia P.M., Murphy R., Azmitia E.C. S-100 protein is released from astroglial cells by stimulation of 5-HT1a receptors and regulates development of serotonin neurons. Brain Res. 528:1990;155-160
33. Whitaker-Azmitia P.M., Wingate M., Borella A., Gerlai R., Roder J. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome. Brain Res. 776:1997;51-60
34. Yan W., Wilson C.C., Haring J.H. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res. Dev. Brain Res. 98:1997;185-190
35. Yasuhara O., Aimi Y., McGeer E.G., Mcgeer P.L. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Res. 652:1994;346-349